HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Seeks To Nix Some Forms From Sunscreen Monograph

This article was originally published in The Rose Sheet

Executive Summary

FDA’s advanced notice of proposed rulemaking starts the process of eliminating several other sunscreen delivery formats from the monograph, despite requests by marketers.

You may also be interested in...



TiO2-Containing Cosmetic Powders Subject Of Prop 65 Settlements

Five marketers of cosmetic powders containing titanium dioxide particles have agreed to settle with NGO the Public Interest Alliance LLC in a case brought under California’s Proposition 65 regulation.

FDA Should Grant Labeling Leeway For Cosmetics With SPF, Council Says

FDA’s recently released final sunscreen rule does not adequately take into account the unique nature of cosmetic products with built-in sunscreen, according to the Personal Care Products Council.

FDA Should Grant Labeling Leeway For Cosmetics With SPF, Council Says

FDA’s recently released final sunscreen rule does not adequately take into account the unique nature of cosmetic products with built-in sunscreen, according to the Personal Care Products Council.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017630

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel